Literature DB >> 34226605

Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram.

Shuai Wang1,2, Yan Deng2, Xiao Yu2, Xue-Wen Zhang2, Cheng-Long Huo2, Zhen-Gang Sun3, Hong Chang4.   

Abstract

The study aimed to evaluate the prognostic significance of preoperative systemic inflammatory biomarkers including albumin to globulin ratio (AGR), neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), and platelet to lymphocyte ratio (PLR) and establish a nomogram in hepatocellular carcinoma (HCC) patients after microwave ablation (MWA). 192 HCC patients receiving MWA as initial therapy from the first ward of hepatobiliary surgery were classified as training cohort. Whereas, 84 patients from the second of hepatobiliary surgery were classified as validation cohort. Kaplan-Meier (KM) method and univariate analyses showed that AGR, NLR, LMR, and PLR were significantly associated with OS in the training cohort. Multivariate analysis including clinicopathologic features screened out independent predictors including ascites, tumor size, cancer embolus, AGR, and PLR. Based on those variables, a nomogram for predicting OS was established. The C-index was 0.794 in the training cohort and 0.772 in the validation cohort. Calibration plots identified the nomogram performed well with an ideal model. Compared with Barcelona Clinic Liver Cancer (BCLC) staging system and simple tumor size, the nomogram showed better predictive ability. Besides, the nomogram discovered the highest diagnostic accuracy in predicting postoperative clinical outcome than the combination of the present models with tumor size. In conclusion, the constructed nomogram could accurately predict individualized survival probability and might support clinician in individual treatment optimization and clinical decision-making.

Entities:  

Year:  2021        PMID: 34226605     DOI: 10.1038/s41598-021-93289-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  36 in total

Review 1.  Management of HCC.

Authors:  Carlos Rodríguez de Lope; Silvia Tremosini; Alejandro Forner; María Reig; Jordi Bruix
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

2.  Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients.

Authors:  Jia-yan Ni; Lin-feng Xu; Hong-liang Sun; Jing-xing Zhou; Yao-ting Chen; Jiang-hong Luo
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-26       Impact factor: 4.553

Review 3.  Inflammatory breast cancer biology: the tumour microenvironment is key.

Authors:  Bora Lim; Wendy A Woodward; Xiaoping Wang; James M Reuben; Naoto T Ueno
Journal:  Nat Rev Cancer       Date:  2018-08       Impact factor: 60.716

4.  Distinction of intrahepatic metastasis from multicentric carcinogenesis in multifocal hepatocellular carcinoma using molecular alterations.

Authors:  Peter Chianchiano; Maryam Kherad Pezhouh; Amy Kim; Claudio Luchini; Andrew Cameron; Matthew J Weiss; Jin He; Lysandra Voltaggio; Kiyoko Oshima; Robert A Anders; Laura D Wood
Journal:  Hum Pathol       Date:  2017-11-24       Impact factor: 3.466

Review 5.  Epidemiology of hepatocellular carcinoma (HCC) in hemophilia.

Authors:  Shrimati Shetty; Nitika Sharma; Kanjaksha Ghosh
Journal:  Crit Rev Oncol Hematol       Date:  2015-12-22       Impact factor: 6.312

Review 6.  New trials and results in systemic treatment of HCC.

Authors:  María Reig; Leonardo Gomes da Fonseca; Sandrine Faivre
Journal:  J Hepatol       Date:  2018-04-11       Impact factor: 25.083

Review 7.  Treatment of hepatocellular carcinoma: a systematic review.

Authors:  Shibo Lin; Katrin Hoffmann; Peter Schemmer
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

Review 8.  Inflammatory role of high salt level in tumor microenvironment (Review).

Authors:  Suneetha Amara; Venkataswarup Tiriveedhi
Journal:  Int J Oncol       Date:  2017-03-27       Impact factor: 5.650

Review 9.  Cancer-related inflammation and treatment effectiveness.

Authors:  Connie I Diakos; Kellie A Charles; Donald C McMillan; Stephen J Clarke
Journal:  Lancet Oncol       Date:  2014-10       Impact factor: 41.316

10.  Prognostic Value Of Preoperative Systemic Inflammatory Biomarkers In Patients With Gallbladder Cancer And The Establishment Of A Nomogram.

Authors:  Yan Deng; Feng Zhang; Xiao Yu; Cheng-Long Huo; Zhen-Gang Sun; Shuai Wang
Journal:  Cancer Manag Res       Date:  2019-10-21       Impact factor: 3.989

View more
  1 in total

1.  Changes in Inflammatory Markers Predict the Prognosis of Resected Hepatocellular Carcinoma with Child-Pugh A.

Authors:  Jing Zhou; Daofeng Yang
Journal:  Curr Oncol       Date:  2022-08-16       Impact factor: 3.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.